Please assess the completion status of the following clinical trial:

Trial Title: Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* At least 40 years of age with a clinical diagnosis of Osteoarthritis (OA)of the knee for 6 months prior to study entry (ARA class I, II, or III).~* Positive therapeutic effect from prior NSAID therapy.~* Worsening of symptoms upon withdrawal of prior treatment.~* With the exception of OA, in otherwise good health~Exclusion Criteria:~* Weight no more than 280 pounds (male or female).~* Recent, sustained use of gastroprotective agents.~* History of arthroscopy of the affected knee within 6 months prior to study entry.~* History of acute ligamentous or meniscal injury of the study joint within the previous 2 years.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).